유세포 분석기 시장 : 기술별, 제품별, 용도별, 국가별 예측 - 경영 임원용 및 컨설턴트용 가이드 - 인공지능(AI) 영향(2026-2030년)

Report Overview:

Flow Cytometry is a mainstay of analytical methods to study cells, but growth is now accelerating as new immuno-oncology and liquid biopsy markets create unprecedented investment in the race to cure cancer. Research vs. Clinical, Bead vs. Gel, its all here in this comprehensive report.

Flow cytometry is a powerful analytical technology used to measure physical and biochemical characteristics of individual cells or particles as they flow through a fluid stream past optical detection systems. By using fluorescently labeled antibodies or probes, flow cytometry enables rapid, multiparameter analysis of cell populations, providing detailed information about cellular phenotype, function, viability, and protein expression. The technology has become an essential tool in biomedical research, clinical diagnostics, drug discovery, and biopharmaceutical development.

The global flow cytometry market is estimated to exceed approximately USD 6-9 billion annually and is projected to grow at compound annual growth rates of approximately 8-11% over the next decade. Growth is driven by expanding applications in immunology, oncology, stem cell research, infectious disease research, and biopharmaceutical development. Increasing adoption of high-parameter cytometry technologies and advances in data analysis software are further supporting market expansion.

Flow cytometry is widely used in both research and clinical settings due to its ability to rapidly analyze thousands of cells per second while simultaneously measuring multiple biological parameters. The technology provides quantitative and reproducible data that supports identification of cell populations, analysis of immune system function, and evaluation of therapeutic responses.

Technology Overview

Flow cytometry systems operate by suspending cells or particles in a fluid stream and passing them through a laser beam. As cells pass through the laser, they scatter light and emit fluorescence signals that are detected by optical sensors. These signals provide information about cell size, complexity, and expression of specific biomarkers.

Fluorescent antibodies or probes are commonly used to label proteins or other cellular components of interest. Multiparameter flow cytometry enables simultaneous measurement of multiple cellular markers, allowing researchers to identify complex cell populations.

Advanced cytometry systems incorporate multiple lasers and detectors to measure dozens of parameters in a single experiment. High-dimensional cytometry techniques enable detailed analysis of immune cell subsets and disease-associated cellular phenotypes.

Fluorescence-activated cell sorting (FACS) systems represent an important segment of the flow cytometry market. Cell sorting technologies enable physical separation of cell populations based on specific characteristics, enabling downstream experimental analysis.

Advances in optical detection systems and fluorescent reagents are improving sensitivity and enabling detection of rare cell populations.

Integration of cytometry platforms with data analysis software supports interpretation of complex datasets.

Key Applications

Flow cytometry is widely used across multiple research and clinical application areas.

Immunology research represents one of the largest application segments. Flow cytometry is used to characterize immune cell populations, analyze immune responses, and evaluate cytokine expression patterns.

Oncology research uses flow cytometry to analyze tumor cell characteristics and identify cancer biomarkers. Flow cytometry is used in clinical hematology laboratories to diagnose leukemias and lymphomas.

Stem cell research uses flow cytometry to identify and isolate stem cell populations based on cell surface markers.

Infectious disease research uses flow cytometry to analyze host immune responses and detect infected cells.

Drug discovery applications use flow cytometry to evaluate effects of candidate compounds on cellular signaling pathways and cell viability.

Biopharmaceutical companies use flow cytometry in development and quality control of biologic drugs and cell therapies.

Flow cytometry is also used in clinical diagnostics to monitor immune system function in transplant patients and individuals with autoimmune diseases.

Applications in vaccine development and immunotherapy research are expanding.

Market Drivers

Several factors are driving growth in the flow cytometry market.

Increasing investment in immunology research is supporting demand for advanced cellular analysis technologies.

Growth in cancer research and immunotherapy development is increasing demand for immunophenotyping tools.

Expansion of biologics and cell therapy pipelines is supporting demand for cell analysis technologies.

Advances in fluorescent reagents and detection systems are enabling high-parameter cytometry experiments.

Increasing use of precision medicine approaches is driving demand for technologies capable of detailed cellular characterization.

Expansion of academic research funding supports adoption of advanced cytometry platforms.

Growth in biotechnology industry supports demand for cell analysis tools.

Increasing interest in systems biology approaches is supporting use of multiparameter cellular analysis technologies.

Advances in automation are improving throughput and reproducibility.

Market Segmentation

The flow cytometry market can be segmented by product type, application, end user, and geographic region.

By product type, instruments represent a significant portion of market value due to high capital cost. Reagents and consumables represent a substantial portion of recurring revenue. Software and services represent additional market segments.

By application, research applications represent a major segment, including immunology, cancer biology, and stem cell research. Clinical diagnostics represent an important segment, particularly in hematology and immunology testing.

End users include academic research institutions, pharmaceutical companies, biotechnology companies, clinical laboratories, and contract research organizations.

North America represents a major regional market due to strong life sciences research activity and biotechnology innovation.

Europe represents a significant market supported by academic research institutions and pharmaceutical companies.

Asia-Pacific markets are expanding due to increasing investment in biotechnology research and healthcare infrastructure.

Government funding for biomedical research supports demand for advanced cytometry technologies.

Competitive Landscape

The flow cytometry market includes instrument manufacturers, reagent suppliers, antibody developers, software providers, and service providers.

Competition is influenced by instrument performance, number of measurable parameters, ease of use, and compatibility with data analysis software.

Companies are investing in development of high-parameter cytometry platforms capable of measuring increasing numbers of cellular markers simultaneously.

Reagent portfolios represent an important component of competitive differentiation.

Integration of instrument platforms with software tools supporting data interpretation represents an important market trend.

Strategic partnerships between instrument manufacturers and reagent suppliers are common.

Intellectual property related to optical technologies and fluorescent probes influences competitive positioning.

Companies are investing in user-friendly software interfaces and automation technologies.

Future Outlook

The flow cytometry market is expected to continue expanding as research in immunology, oncology, and cell therapy increases.

Advances in high-dimensional cytometry technologies may improve ability to characterize complex cell populations.

Automation of sample preparation workflows may improve throughput and reproducibility.

Artificial intelligence tools may improve interpretation of high-dimensional cytometry datasets.

Integration of cytometry technologies with genomic and proteomic data may support systems biology research.

Expansion of cell therapy development may increase demand for cell characterization tools.

Overall, flow cytometry represents a critical enabling technology supporting modern biomedical research and clinical diagnostics. Continued advances in instrumentation, reagents, and data analysis tools are expected to support sustained market growth.

Table of Contents

1 Market Guides

• 1.1 Situation Analysis
• 1.2 Guide for Executives and Marketing Staff
• 1.3 Guide for Investment Analysts and Management Consultants
• 1.4 Impact of Artificial Intelligence

2 Introduction and Market Definition

• 2.1 What is Flow Cytometry?
  • 2.1.1 Cell Sorting
  • 2.1.2 Academic Use
• 2.2 Market Definition
  • 2.2.1 Market Size.
  • 2.2.2 Currency.
  • 2.2.3 Years.
• 2.3 Methodology
  • 2.3.1 Methodology
  • 2.3.2 Sources
  • 2.3.3 Authors
• 2.4 U.S. Medical Market and Pharmceutical Research Spending -
• Perspective
  • 2.4.1 U.S. Expenditures for Pharmaceutical Research

3 Flow Cytometry - Guide to Technology

• 3.1 Flow Cytometers
• 3.2 Hardware
  • 3.2.1 Fluidics
    • 3.2.1.1 Hydrodynamic Focusing
    • 3.2.1.2 Acoustic Focusing
  • 3.2.2 Optics and electronics
    • 3.2.2.1 Optical filters
    • 3.2.2.2 Prisms, gratings, and spectral flow cytometry
    • 3.2.2.3 Imaging flow cytometry
• 3.3 Data analysis
  • 3.3.1 Compensation
  • 3.3.2 Gating
  • 3.3.3 Computational analysis
  • 3.3.4 FMO controls
• 3.4 Cell Sorting
• 3.5 Labels
  • 3.5.1 Fluorescent labels
  • 3.5.2 Quantum dots
  • 3.5.3 Isotope labeling
• 3.6 Bead Array
• 3.7 Impedance flow cytometry
• 3.8 Flow Cytometry Applications
• 3.9 Cell Viability Assays
• 3.10 Cell Proliferation Assays
• 3.11 Cytotoxicity Assays
• 3.12 Cell Senescence Assays
• 3.13 Apoptosis
• 3.14 Autophagy
• 3.15 Necrosis
• 3.16 Oxidative Stress
• 3.17 Signalling Pathways, GPCR
• 3.18 Immune Regulation & Inhibition
• 3.19 Reporter Gene Technology

4 Industry Overview

• 4.1 Players in a Dynamic Market
  • 4.1.1 Academic Research Lab
  • 4.1.2 Contract Research Organization
  • 4.1.3 Genomic Instrumentation Supplier
  • 4.1.4 Cell Separation and Viewing Supplier
  • 4.1.5 Cell Line and Reagent Supplier
  • 4.1.6 Pharmaceutical Company
  • 4.1.7 Audit Body
  • 4.1.8 Certification Body

5 Market Trends

• 5.1 Factors Driving Growth
  • 5.1.1 The Move to Cell Based Analytics
  • 5.1.2 Immuno-oncology
  • 5.1.3 Genomic Blizzard
  • 5.1.4 Technology Convergence
• 5.2 Factors Limiting Growth
  • 5.2.1 Genomic Technology Competition
  • 5.2.2 Instrument Integration
  • 5.2.3 Maturity
• 5.3 Technology Development
  • 5.3.1 Software
  • 5.3.2 Instrument Size
  • 5.3.3 Larger Panels
  • 5.3.4 The Next Five Years

6 Flow Cytometry Recent Developments

• 6.1 Recent Developments - Importance and How to Use This Section
  • 6.1.1 Importance of These Developments
  • 6.1.2 How to Use This Section
• 6.2 CyPathR Lung Cancer Test Supports Flow Cytometry Guidelines
• 6.3 Flow Cytometry Usedto Study MRD
• 6.4 Light-field flow cytometry for multiparametric 3D single-cell analysis
• 6.5 Virax Biolabs Partners for Long COVID Study
• 6.6 Agilent Aims for Early-Stage CDx Development Deals
• 6.7 Navigate BioPharma Services To Collaborate with BD
• 6.8 bioAffinity Technologies Acquires Assets of Precision Pathology Services
• 6.9 Bio-Rad enhances flow cytometry capabilities
• 6.10 BD Launches New Robotic System
• 6.11 Hybrid Flow Cytometer
• 6.12 BD and A*STAR collaborate
• 6.13 Cytek Biosciences to Acquire Flow Cytometry Business
• 6.14 METAFORA Launches a Digital Cytometry Analysis Platform
• 6.15 In Vitro Potency Assays Utilize Flow Cytometry
• 6.16 Celerion to Offer Molecular and Cell Biology Testing
• 6.17 Beckman Coulter launches Cytobank v10 Platform
• 6.18 NASA Deploys Flow Cytometer in Space
• 6.19 BD, Labcorp to Develop Flow Cytometry-Based Companion Diagnostics
• 6.20 Slingshot Biosciences Partners With Cambridge Bioscience to Distribute Synthetic Cells
• 6.21 Canopy Bio Targeting High-Throughput Spatial Proteomics
• 6.22 Becton Dickinson Advancing Rapid Image-Based Cell Sorting Tech
• 6.23 Insightful Science Acquires Data Science Company Omiq
• 6.24 Single-Cell Startup Nodexus Raises $30M
• 6.25 Bio-Rad Laboratories StarBright UltraViolet 400 Dye for Flow Cytometry
• 6.26 Cytek Biosciences Acquires Cell Analysis Business of Tonbo Biosciences
• 6.27 Becton Dickinson FACSymphony A5 SE Cell Analyzer
• 6.28 Biotium ExoBrite EV Membrane Staining Kits
• 6.29 Cytek Biosciences Prices $200M Initial Public Offering
• 6.30 Invivoscribe 12-Color Flow Cytometry Service
• 6.31 Beckman Coulter launches CytoFLEX SRT benchtop cell sorter
• 6.32 Thermo Fisher Acquires Cell Sorting Technology From Propel Labs
• 6.33 Thermo Fisher Acquires Programmable Dye Platform Pioneer Phitonex
• 6.34 NGS Bests Flow Cytometry for MRD-Based Prediction
• 6.35 Bio-Rad Launches New StarBright Dyes
• 6.36 Cytek Biosciences Closes $120M Financing Round
• 6.37 Cellular Analytics Detects Early Mesothelioma Using Liquid Biopsy
• 6.38 Cytek Biosciences Gets CE Mark for Flow Cytometer
• 6.39 Aigenpulse launches suite to automate flow cytometry
• 6.40 Sysmex Partec to Distribute De Novo Flow Cytometry Software

7 Profiles of Key Flow Cytometry Companies

• 7.1 Agilent/Dako
• 7.2 Amphasys
• 7.3 Apogee Flow Systems
• 7.4 Applied Cytometry
• 7.5 Astrolabe Diagnostics
• 7.6 Beckman Coulter Diagnostics
• 7.7 Becton, Dickinson and Company
• 7.8 BennuBio
• 7.9 bioMerieux Diagnostics
• 7.10 Bio-Rad Laboratories, Inc.
• 7.11 Cytek Biosciences
• 7.12 Cytognos
• 7.13 Cytonome
• 7.14 De Novo Software
• 7.15 Gemini Bio
• 7.16 Kinetic River
• 7.17 Logos Biosystems
• 7.18 Luminex Corp (DiaSorin)
• 7.19 Miltenyi Biotec
• 7.20 Molecular Devices
• 7.21 Nanion
• 7.22 NanoCellect Biotechnology
• 7.23 Omiq
• 7.24 On-Chip Biotechnologies
• 7.25 Partek
• 7.26 Sartorius
• 7.27 SBT Instruments
• 7.28 Singleron Biotechnologies
• 7.29 Sony Biotechnology
• 7.30 Standard BioTools
• 7.31 Stratedigm
• 7.32 Sysmex
• 7.33 Sysmex Partec
• 7.34 Tecan
• 7.35 Tercen Data
• 7.36 Thermo Fisher Scientific Inc.
• 7.37 TissueGnostics
• 7.38 Union Biometrica
• 7.39 Verity Software House
• 7.40 Yokogawa Fluid Imaging Technologies

8 Flow Cytometry Global Market Overview

• 8.1 Global Market Overview by Country
  • 8.1.1 Table - Global Market by Country
  • 8.1.2 Chart - Global Market by Country
• 8.2 Global Market Size by Product - Overview
  • 8.2.1 Table - Global Market by Product
  • 8.2.2 Chart - Global Market by Product - Base/Final Year Comparison
  • 8.2.3 Chart - Global Market by Product - Base Year
  • 8.2.4 Chart - Global Market by Product - Final Year
  • 8.2.5 Chart - Global Market by Product - Share by Year
  • 8.2.6 Chart - Global Market by Product - Segment Growth
• 8.3 Global Market Size by Application - Overview
  • 8.3.1 Table - Global Market by Application
  • 8.3.2 Chart - Global Market by Application - Base/Final Year Comparison
  • 8.3.3 Chart - Global Market by Application - Base Year
  • 8.3.4 Chart - Global Market by Application - Final Year
  • 8.3.5 Chart - Global Market by Application - Share by Year
  • 8.3.6 Chart - Global Market by Application - Segment Growth
• 8.4 Global Market Size by Technology - Overview
  • 8.4.1 Table - Global Market by Technology
  • 8.4.2 Chart - Global Market by Technology - Base/Final Year Comparison
  • 8.4.3 Chart - Global Market by Technology - Base Year
  • 8.4.4 Chart - Global Market by Technology - Final Year
  • 8.4.5 Chart - Global Market by Technology - Share by Year
  • 8.4.6 Chart - Global Market by Technology - Segment Growth

9 Global Market by Product

• 9.1 Reagent Market
  • 9.1.1 Table - Reagent Market by Country
  • 9.1.2 Chart - Reagent Market Segment Growth
• 9.2 Instrument Market
  • 9.2.1 Table - Instrument Market by Country
  • 9.2.2 Chart - Instrument Market Segment Growth
• 9.3 Services Market
  • 9.3.1 Table - Services Market by Country
  • 9.3.2 Chart - Services Market Segment Growth
• 9.4 Software Market
  • 9.4.1 Table - Software Market by Country
  • 9.4.2 Chart - Software Market Segment Growth

10 Global Market by Application

• 10.1 Research Market
  • 10.1.1 Table - Research Market by Country
  • 10.1.2 Chart - Research Market Segment Growth
• 10.2 Clinical Market
  • 10.2.1 Table - Clinical Market by Country
  • 10.2.2 Chart - Clinical Market Segment Growth
• 10.3 Industrial Market
  • 10.3.1 Table - Industrial Market by Country
  • 10.3.2 Chart - Industrial Market Segment Growth
• 10.4 Other Application Market
  • 10.4.1 Table - Other Application Market by Country
  • 10.4.2 Chart - Other Application Market Segment Growth

11 Global Market by Technology

• 11.1 Gel Market
  • 11.1.1 Table - Gel Market by Country
  • 11.1.2 Chart - Gel Market Segment Growth
• 11.2 Bead Market
  • 11.2.1 Table - Bead Market by Country
  • 11.2.2 Chart - Bead Market Segment Growth

12 Appendices

• 12.1 United States Medicare System: Clinical Laboratory Fees Schedule
• 12.2 FDA Cancer Drug Approvals by Year
• 12.3 Clinical Trials Started 2010 to 2016
• 12.4 Share of Pharma R&D by Country

Table of Tables

• Table 1 Some Characterics Measured by Flow Cytometry
• Table 2 Some Common Viability Assays
• Table 3 Oxidative Stress Related Diseases
• Table 4 Important Signalling Pathways
• Table 5 Market Players by Type
• Table 6 Four Factors Driving Growth
• Table 7 Three Factors Limiting Growth
• Table 8 Global Market by Country/Region
• Table 9 Global Market by Product
• Table 10 Global Market by Application
• Table 11 Global Market by Technology
• Table 12 Reagent Market by Country
• Table 13 Instrument Market by Country
• Table 14 Services Market by Country
• Table 15 Software Market by Country
• Table 16 Research Market by Country
• Table 17 Clinical Market by Country
• Table 18 Industrial Market by Country
• Table 19 Other Application Market by Country
• Table 20 Gel Market by Country
• Table 21 Bead Market by Country
• Table 22 Clinical Lab Fee Schedule

Table of Figures

• Figure 1 Pharmaceutical Research Expenditures ($Billion)
• Figure 2 Oxidative Stress and Free Radical Toxicity
• Figure 3 FDA Cancer Drug Approvals
• Figure 4 Immunotherapy vs Traditional
• Figure 5 Growth rates of Flow Cytometry by Product Class
• Figure 6 Market Size by Country
• Figure 7 Global Market by Product - Base vs. Final Year
• Figure 8 Product Market Base Year
• Figure 9 Product Market Final Year
• Figure 10 Product Share by Year
• Figure 11 Product Segment Growth
• Figure 12 Global Market by Application - Base vs. Final Year
• Figure 13 Application Market Base Year
• Figure 14 Application Market Final Year
• Figure 15 Application Share by Year
• Figure 16 Application Segment Growth
• Figure 17 Global Market by Technology - Base vs. Final Year
• Figure 18 Technology Market Base Year
• Figure 19 Technology Market Final Year
• Figure 20 Technology Share by Year